Search Results

management of early-stage tumors and treatment failure with isolated local recurrence. In medically operable patients, total hysterectomy, bilateral salpingo-oophorectomy, and pelvic and para-aortic lymph node dissection is the recommended surgery for

node dissection (ILND) is recommended, and again DSNB is a category 2B recommendation. “We are somewhat cautious in promoting this type of technique [DSNB],” admitted Dr. Spiess. For those with more aggressive primary tumor, the gold standard remains

have a 2.7-cm moderately differentiated invasive ductal carcinoma that was estrogen receptor–positive/progesterone receptor–positive/HER2-positive (ER+/PR+/HER2+) on immunohistochemistry. Lymph node dissection was negative in 0 of 23 nodes. Surgical

Case Report A 47-year-old Asian woman presented at our institution with stage IIIA (T1cN2M0) invasive ductal carcinoma. She underwent breast-conserving surgery and axillary lymph node dissection. Her tumor was found to be grade II, estrogen

for Breast Cancer. “An incredible amount of progress has been made in surgical procedures and treatment based on tumor characteristics.” From a surgical standpoint, said Dr. Gradishar, axillary lymph node dissection was the standard of care in 1996

management strategy for stage I TC. 14 For stage I nonseminoma, adjuvant chemotherapy with 1 cycle of bleomycin/etoposide/cisplatin (BEPX1) and retroperitoneal lymph node dissection (RPLND) are other options, whereas adjuvant chemotherapy with 1 cycle of

. Therefore, chemotherapy was discontinued and she underwent a robot-assisted radical cystectomy with open construction of an ileal neobladder and an extended bilateral pelvic lymph node dissection. Figure 1 CT scan showing irregular necrotic mass at

. Int J Gynecol Cancer 2015 ; 25 : 1437 – 1444 . 5. Alagkiozidis I Weedon J Grossman A . Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma: a

predictor of survival and determines the indication for additional surgery (ie, complete lymph node dissection), systemic adjuvant therapy, surveillance imaging, and frequency of clinical follow-up. However, controversy remains regarding the most appropriate

as long as the patient has no contraindications to this treatment. Lymphadenectomy The extent of lymph node dissection needed during radical cystectomy for MIBC is controversial. 8 Data show that a more extensive lymph node dissection may